Sell RIM!: Against ...
Abiomed Inc. (ABMD: NASDAQ)
$19.77 0.86 | 4.55%
06/04/12 - 04:00 PM ET
Company Cash Flow
| Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 0.00 | -11.76M | -19.02M | -31.60M |
| Operating Gains/Losses | n.a. | -427.00K | -6.34M | -148.00K |
| Extraordinary Gains / Losses | n.a. | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | n.a. | -1.92M | 2.21M | -2.54M |
| (Increase) Decrease in Inventories | n.a. | -1.51M | 927.00K | -1.60M |
| (Increase) Decrease In Other Current Assets | n.a. | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | n.a. | 2.48M | -1.39M | -2.40M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 605.00K | 2.37M | 2.02M |
| (Increase) Decrease In Other Working Capital | n.a. | 682.00K | 0.00 | 0.00 |
| Other Non-Cash Items | n.a. | 8.34M | 8.58M | 11.23M |
| Net Cash From Continuing Operations | n.a. | 1.57M | -7.36M | -18.30M |
| Net Cash From Discontinued Operations | n.a. | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 0.00 | 1.57M | -7.36M | -18.30M |
| Sale of Property, Plant & Equipment | n.a. | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | n.a. | 7.00M | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | 0.00 | -1.80M | -1.80M | -3.75M |
| Acquisitions | n.a. | 0.00 | 4.64M | 0.00 |
| Purchases of Short-Term Investments | n.a. | -8.00M | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 456.00K | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 0.00 | -2.35M | 8.82M | -26.80M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | n.a. | 313.00K | 979.00K | 46.94M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | n.a. | 1.06M | 0.00 | -711.00K |
| Net Cash From Financing Activities | 0.00 | 1.37M | 979.00K | 46.23M |
| Effect of Exchange Rate Changes | 0.00 | 447.00K | 568.00K | -1.38M |
| Net Change in Cash & Cash Equivalents | 0.00 | 1.04M | 3.00M | -257.00K |
Portfolios with ABMD
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- Contributor10 Top Morningstar M&A Stoc...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks At New 52-Week Highs...
- ContributorTop Stocks of the 10 Best M...
- UserPART 6 JPMorgan 28th Annual...
- User52 week high 52 week low
- UserRAPTOR SPRTD-1102091914
- UserPART 5 JPMorgan 27th Annual...
Latest ABMD Headlines from TheStreet
- Abiomed Stock Falls On Unusually High Volume (ABMD) 05.22.12 | 04:05 pm
- Abiomed Stock Gaps Up On Today's Open (ABMD) 05.16.12 | 09:05 am
- Abiomed Stock Hits New 52-Week High (ABMD) 05.01.12 | 10:05 am
- 'Mad Money Lightning Round': Caution on Citigroup 03.02.12 | 07:03 pm
- Abiomed Rises On Unusually High Volume (ABMD) 02.08.12 | 03:02 pm
- Abiomed Stock Falls On Unusually High Volume (ABMD) 02.07.12 | 12:02 pm
- Abiomed Reaches New 52-Week High (ABMD) 02.06.12 | 11:02 am
- 8 Stocks Soaring on Unusual Volume 02.03.12 | 04:02 pm
- Abiomed Stock Gaps Up On Today's Open (ABMD) 02.03.12 | 08:02 am
- 10 Top Morningstar M&A Stock Picks for 2012 01.20.12 | 01:01 pm
Press Releases for ABMD
- Abiomed To Present At Deutsche Bank 37Th Annual Healthcare Conference - Business Wire 05.01.12 | 08:05 am
- Abiomed Receives CE Mark For Impella CVAD - Business Wire 04.12.12 | 08:04 am
- Abiomed Announces First Patient Supported With Impella CVAD - Business Wire 04.03.12 | 08:04 am
- Abiomed Appoints Susan Vissers Lisa As Senior Director Of Investor Relations And Corporate Development - Business Wire 03.21.12 | 08:03 am
- Abiomed Announces Schedule Of Events At American College Of Cardiology 2012 Scientific Sessions - Business Wire 03.20.12 | 08:03 am
- Abiomed To Present At The Cowen 32nd Annual Healthcare Conference - Business Wire 03.02.12 | 11:03 am
- Abiomed To Present At Citi 2012 Global Healthcare Conference - Business Wire 02.22.12 | 08:02 am
- Abiomed Reports Record Revenue Of $32.2 Million And Earnings Of $2.9 Million For Third Quarter Of Fiscal 2012 - Business Wire 02.03.12 | 07:02 am
- New Clinical Data For Symphony Presented In Late Breaking Clinical Trials Session At The Society Of Thoracic Surgeons 2012 Annual Meeting - Business Wire 01.31.12 | 08:01 am
- Abiomed Third Quarter Fiscal 2012 Earnings And Conference Call Notification - Business Wire 01.26.12 | 12:01 pm
Partner Headlines for ABMD
- Abiomed Beats, Posts Profit - Analyst Blog - Zacks 05.17.12 | 10:05 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 04.09.12 | 09:04 am
- Abiomed Tops, Swings to Black - Analyst Blog - Zacks 02.06.12 | 09:02 am
- Wunderlich Maintains Buy, $24 Target on Abiomed - Benzinga 12.12.11 | 09:12 am
- Abiomed Raised to Outperform - Analyst Blog - Zacks 11.11.11 | 07:11 pm
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 11.07.11 | 09:11 am
- Neutral View on Abiomed - Analyst Blog - Zacks 08.16.11 | 06:08 pm
- Healthcare Stocks in the News on Tuesday - Seeking Alpha 06.29.11 | 09:06 am
- UPDATE 1-US FDA warns Abiomed on marketing of heart pump - Reuters 06.28.11 | 11:06 am
- Cramer's Mad Money - 6 Earnings to Watch in the Coming Week (6/3/11) - Seeking Alpha 06.05.11 | 06:06 am





